KROIN DAVID

USNatural personDirector

Insider

KROIN DAVID

USNatural personDirector2 companies · 24mo

Transactions

Issuers

Buys / Sells

2/59

Last tx

10 Feb 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NEKTAR THERAPEUTICS	18,344,000	reported	10 May 2024	tx 1−56,000
LB PHARMACEUTICALS INC	378,444	reported	06 Feb 2026	tx 2+472,369
CONNECTURE INC	36,493	reported	10 Jun 2015	tx 5+152,127−1,375,733
Biodel Inc	20,000	reported	02 Mar 2010	tx 61+1,308,756−1,979,769
MEMORY PHARMACEUTICALS CORP

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
10 Feb 2026	TENDER	DYNAVAX TECHNOLOGIES CORP	15,726,349	—
06 Feb 2026	PURCHASE	LB PHARMACEUTICALS INC	93,925	21.17 USD	deriv
06 Feb 2026	PURCHASE	LB PHARMACEUTICALS INC	378,444	21.17 USD	deriv
10 May 2024	SALE	NEKTAR THERAPEUTICS	56,000	1.78 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
NEKTAR THERAPEUTICS	18,344,000	reported	10 May 2024	tx 1−56,000
LB PHARMACEUTICALS INC	378,444	reported	06 Feb 2026	tx 2+472,369
CONNECTURE INC	36,493	reported	10 Jun 2015	tx 5+152,127−1,375,733
Biodel Inc	20,000	reported	02 Mar 2010	tx 61+1,308,756−1,979,769
MEMORY PHARMACEUTICALS CORP

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
10 Feb 2026	TENDER	DYNAVAX TECHNOLOGIES CORP	15,726,349	—
06 Feb 2026	PURCHASE	LB PHARMACEUTICALS INC	93,925	21.17 USD	deriv
06 Feb 2026	PURCHASE	LB PHARMACEUTICALS INC	378,444	21.17 USD	deriv
10 May 2024	SALE	NEKTAR THERAPEUTICS	56,000	1.78 USD